Ozempic producer CEO in hot seat in Senate hearing over cost of weight loss drug

United States News News

Ozempic producer CEO in hot seat in Senate hearing over cost of weight loss drug
United States Latest News,United States Headlines
  • 📰 ABC7NY
  • ⏱ Reading Time:
  • 43 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 51%

Senators contend the life saving drug is too high for many patients.

Senators grilled Novo Nordisk CEO Lars Jorgensen Tuesday at a hearing over the costs of Ozempic, Wegovy and similar weight loss drugs.

The drugs have risen in popularity for diabetic patients and others looking to combat obesity since they were approved, however, senators of the Health, Education, Labor, and Pensions Committee grilled the CEO. They argued the price of Ozempic, which costs as much as $900 a month, is too high for many patients. By comparison, Ozempic costs $155 monthly in Canada, according to the committee.

Sen. Bernie Sanders, I-Vt., speaks during a Senate Health, Education, Labor, and Pensions Committee business meeting on Capitol Hill, Thursday, Sept. 19, 2024, in Washington."What these doctors are telling us is if the price of Ozempic and Wegovy is not reduced, many of their patients who have diabetes and obesity, especially lower-income Americans often minority Americans, will not be able to afford these drugs," he said.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

ABC7NY /  🏆 592. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Ozempic maker to testify before Senate committee on weight loss drug pricesOzempic maker to testify before Senate committee on weight loss drug pricesNovo Nordisk CEO Lars Fruergaard Jørgensen is testifying before the Senate Health, Education, Labor and Pension committee on Tuesday.
Read more »

Senators expected to hold Steward Health Care CEO Ralph de la Torre in contemptSenators expected to hold Steward Health Care CEO Ralph de la Torre in contemptThe CEO of the troubled hospital chain has signaled he will not appear at a Congressional hearing on Tuesday, despite a subpoena calling for his testimony.
Read more »

Senators slam Steward Health Care CEO, plan contempt voteSenators slam Steward Health Care CEO, plan contempt voteU.S. Senators on Thursday called Steward Health Care’s CEO the poster child for corporate greed in health care and vowed to vote next week to hold him in civil and criminal contempt.
Read more »

Senate committee to vote to hold Steward Health Care CEO in contemptSenate committee to vote to hold Steward Health Care CEO in contemptMembers of a Senate committee looking into the Steward Health Care bankruptcy said they plan to vote next week to adopt two resolutions to hold Steward CEO Ralph de la Torre in contempt after he refused to attend a hearing Thursday despite being issued a subpoena.
Read more »

Senate committee to vote to hold Steward Health Care CEO in contemptSenate committee to vote to hold Steward Health Care CEO in contemptMembers of a Senate committee looking into the Steward Health Care bankruptcy said they plan to vote next week to adopt two resolutions to hold Steward CEO Ralph de la Torre in contempt after he refused to attend a hearing Thursday despite being issued a subpoena.
Read more »

Senate committee to vote to hold Steward Health Care CEO in contemptSenate committee to vote to hold Steward Health Care CEO in contemptMembers of a Senate committee looking into the Steward Health Care bankruptcy said they plan to vote next week to adopt two resolutions to hold Steward CEO Ralph de la Torre in contempt after he refused to attend a hearing Thursday despite being issued a subpoena.
Read more »



Render Time: 2025-02-21 05:02:13